Endocrinology/Hormones
Endocrinology/hormone inhibitors are compounds that block the action of hormones or interfere with hormone signaling pathways. These inhibitors are essential for studying the regulation of endocrine systems and for developing treatments for hormone-related diseases, such as diabetes, thyroid disorders, and hormone-dependent cancers. By modulating hormone activity, these inhibitors can help elucidate the complex interactions within the endocrine system. At CymitQuimica, we offer a wide range of high-quality endocrinology/hormone inhibitors to support your research in endocrinology, pharmacology, and medical sciences.
Subcategories of "Endocrinology/Hormones"
- Androgen Receptor(209 products)
- Annexin A(11 products)
- Aromatase(20 products)
- Estrogen/progestogen Receptor(49 products)
- GPR(1 products)
- Glucocorticoid Receptor(153 products)
- LHRH(1 products)
- Opioid Receptor(298 products)
- Prostaglandin Receptor(120 products)
- RAAS(87 products)
- Reductase(52 products)
- Somatostatin(49 products)
- Thyroid hormone receptor(THR)(26 products)
- Vasopressin Receptor(44 products)
Show 6 more subcategories
Found 3184 products of "Endocrinology/Hormones"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Estrone acetate
CAS:<p>Estrone acetate (Hogival) is an estrogen derivative and an activator of estrogen receptors (ER). This compound can enhance breast development, stimulate the secretion of pituitary prolactin, and induce both the proliferation and activation of lactotrophs, evidenced by the reduction in prolactin storage granule size and the increase in the volume density of the rough endoplasmic reticulum and Golgi apparatus. Estrone acetate holds potential for endocrinological research and for investigating the mechanisms by which estrogen influences pituitary function, prolactin regulation, and breast tumor models.</p>Formula:C20H24O3Color and Shape:SolidMolecular weight:312.403ORIC-101
CAS:<p>ORIC-101 is a highly effective and selective glucocorticoid receptor antagonist (EC50: 5.6 nM). It also has anti-cancer activity.</p>Formula:C34H47NO2Purity:98%Color and Shape:SolidMolecular weight:501.74Estrogen receptor antagonist 4
CAS:<p>Estrogen receptor antagonist 4 blocks ER, impacting cell growth and cancer research potential.</p>Formula:C23H29BF4N4O2Color and Shape:SolidMolecular weight:480.31Androstatrione
CAS:<p>Androstatrione is an androgenic compound.</p>Formula:C19H26O3Color and Shape:SolidMolecular weight:302.41Metahexestrol
CAS:<p>Metahexestrol is an inhibitor of the estrogen receptor (E2R) with antitumor activity. It significantly inhibits the proliferation of estrogen receptor-positive MCF-7 human breast cancer cell line with an ED50 of 1.0 μM. Additionally, Metahexestrol shows inhibitory activity in estrogen receptor-negative MDA-MB-231 cell lines, and its antiproliferative effect is not reversed by estrogen, suggesting that its mechanism may be partially independent of the E2R pathway. Metahexestrol is applicable in research on estrogen-dependent breast cancer.</p>Formula:C18H22O2Color and Shape:SolidMolecular weight:270.366GC 14
CAS:<p>GC 14 is a selective thyroid hormone receptor antagonist, with IC50 values of 200 nM and 35 nM for hTRα and hTRβ, respectively.</p>Formula:C26H27NO6Purity:98%Color and Shape:SolidMolecular weight:449.5LIT-001 free base
CAS:<p>LIT-001, a nonpeptide OT-R agonist, enhances mouse autism-like behavior, with EC50=55 nM and Ki=226 nM.</p>Formula:C28H33N7O2SPurity:98%Color and Shape:SolidMolecular weight:531.67Opioid receptor antagonist 1
CAS:<p>Opioid receptor antagonist 1 (Compound 10) is an Orvinol-based antagonist of opioid receptors. It exhibits activity as an antagonist against the analgesic properties of morphine.</p>Formula:C24H29ClF3NO4Color and Shape:SolidMolecular weight:487.94CH5447240
CAS:<p>CH5447240: potent hPTHR1 agonist, treats Hypoparathyroidism, EC50 12 nM, 55% oral bioavailability, raises rat serum calcium.</p>Formula:C26H39N5O4SPurity:98%Color and Shape:SolidMolecular weight:517.68ERβ agonist-1
CAS:<p>ERβagonist-1 (Compound 8) functions as a dual-active selective ERβ agonist (EC50: 46.8 nM) and an AR antagonist (IC50: 1555 nM). By binding to ERβ, it activates its signaling pathways while simultaneously inhibiting AR activity. Retaining selective ERβ agonist activity in mouse models, ERβagonist-1 is applicable in prostate cancer research.</p>Formula:C25H36O2Color and Shape:SolidMolecular weight:368.55ID11916
CAS:<p>ID11916 is an orally active compound functioning as both an androgen receptor (AR) antagonist and a phosphodiesterase 5 (PDE5) inhibitor. It disrupts androgen binding to AR, impedes nuclear translocation, and blocks androgen-dependent transcriptional activity of AR, while simultaneously elevating intracellular cGMP levels by inhibiting PKG activation. Moreover, ID11916 exhibits potent anticancer effects in prostate cancer cell lines VCaP and 22Rv1, as well as in AR-positive breast cancer cell line SK-BR-3.</p>Formula:C29H27F3N8O3SColor and Shape:SolidMolecular weight:624.637AR antagonist 11
CAS:<p>AR antagonist 11 (Compound c2) is a selective androgen receptor antagonist with an IC50 of 0.019 μM. It is also effective against the ARF877L/T878A mutant (IC50: 1.03 μM). Additionally, AR antagonist 11 inhibits LNCaP cell proliferation and decreases PSA protein expression (IC50: 0.54 μM). This compound is applicable in prostate cancer (PCa) research.</p>Formula:C20H17ClN2OColor and Shape:SolidMolecular weight:336.815LEO 134310
CAS:<p>LEO 134310: Selective, non-steroidal GR agonist with 14 nM EC50, for topical skin disease treatment.</p>Formula:C34H40N2O8Color and Shape:SolidMolecular weight:604.69EN1441
CAS:<p>EN1441 is a covalent degrader that targets the androgen receptor (AR) with an EC50 value of 4.2 μM, as well as its truncated variant AR-V7. It selectively and effectively degrades AR and AR-V7 in androgen-independent prostate cancer cells. EN1441 holds potential for research into androgen-independent prostate cancer.</p>Formula:C13H13ClN2O2Color and Shape:SolidMolecular weight:264.708Estrogen receptor antagonist 7
CAS:<p>ER antagonist 7, compound 13, inhibits ERs, halts breast/ovarian cancer cell growth, has anticancer properties.</p>Formula:C23H17N3O4Color and Shape:SolidMolecular weight:399.4AR antagonist 10
CAS:<p>AR antagonist 10 (Compound Y5) is a potent, orally active androgen receptor (AR) antagonist with an IC50 value of 0.04 μM. It demonstrates a dual mechanism of action: antagonizing AR by disrupting AR dimerization and inducing AR degradation through the ubiquitin-proteasome pathway. This compound shows excellent activity against various resistant AR mutants and effectively inhibits the growth of LNCaP xenograft tumors. AR antagonist 10 is applicable for research in resistant prostate cancer.</p>Formula:C18H17ClN4O3SColor and Shape:SolidMolecular weight:404.871PBPE hydrochloride
CAS:<p>PBPE hydrochloride is a derivative of tamoxifen and functions as a selective ligand for antiestrogen binding sites (AEBS). The binding affinity (Ki) of PBPE hydrochloride and MBPE to AEBS is 8.79 nM and 17.57 nM, respectively.</p>Formula:C19H24ClNOColor and Shape:SolidMolecular weight:317.853Estrogen receptor modulator 11
CAS:<p>Estrogen receptor modulator11 (Compound 27) is a tetrahydroisoquinoline derivative. It exhibits affinity for the estrogen receptor (ER), with IC50 values of 285 nM for ERα and 421 nM for ERβ. Estrogen receptor modulator11 does not demonstrate antagonist activity in MCF-7 cell assays.</p>Formula:C21H18FNOColor and Shape:SolidMolecular weight:319.372Bromadoline
CAS:<p>Bromadoline is an opioid compound that exhibits anti-nociceptive properties in rodents.</p>Formula:C15H21BrN2OColor and Shape:SolidMolecular weight:325.244Triisopropyl phosphate
CAS:<p>Triisopropyl phosphate inhibits TFF1 and EGR3 gene expression and exhibits anti-estrogenic activity by suppressing Estradiol-induced proliferation of MCF-7 cells, with an EC50 of 341 μM. Additionally, Triisopropyl phosphate reduces estrogen response element (ERE)-stimulated luciferase activity in MVLN cells, with an EC50 of 900 μM.</p>Formula:C9H21O4PColor and Shape:SolidMolecular weight:224.234KNT-127
CAS:<p>KNT-127 is an agonist of δ-Opioid receptor.</p>Formula:C24H24N2O2Purity:98%Color and Shape:SolidMolecular weight:372.46AP5
CAS:<p>AP5: GPR40 agonist, positive allosteric modulator; rat hIP1 EC50: 0.49 nM.</p>Formula:C28H28FNO4Purity:98%Color and Shape:SolidMolecular weight:461.52Naltrindole 5′-isothiocyanate
CAS:<p>Naltrindole 5′-isothiocyanate (5'-NTII) is an irreversible delta opioid receptor antagonist that counters the analgesic effects induced by DSLET without altering the effects caused by DPDPE.</p>Formula:C27H25N3O3SColor and Shape:SolidMolecular weight:471.571Urotensin-II receptor antagonist-1
CAS:<p>Urotensin-II receptor antagonist-1 (compound 1) is a human Urotensin II receptor antagonist with low oral bioavailability (F=0-3% in rats) and a Ki of 16 nM in HEK293 cells expressing human recombinant UT receptors. It inhibits cytochrome P450 enzymes (IC50=0.75 μM for CYP2D6; 1.4 μM for CYP3A4), suppresses κ opioid receptors (EC50=3.2 μM), and targets cardiac sodium channels (Ki=2.5 μM).</p>Formula:C25H31Cl2N3OColor and Shape:SolidMolecular weight:460.439Novokinin
CAS:<p>Angiotensin AT2 receptor agonist</p>Formula:C39H61N11O7Purity:98%Color and Shape:SolidMolecular weight:795.975′-Guanidinonaltrindole
CAS:<p>5′-Guanidinonaltrindole (GNTI) is a selective antagonist of the kappa opioid receptor.</p>Formula:C27H29N5O3Color and Shape:SolidMolecular weight:471.551BMS-248360
CAS:<p>BMS-248360: Oral dual hAT1/hETA antagonist with Kis of 10nM & 1.9nM, respectively; treats hypertension.</p>Formula:C36H45N5O5SPurity:98%Color and Shape:SolidMolecular weight:659.84GDC-0927 Racemate
CAS:<p>GDC-0927 Racemate is a degrader of estrogen receptor, is used in the research of ER-related diseases, potently inhibits ER-α activity, with an IC50 of 0.2 nM.</p>Formula:C28H28FNO4Purity:98%Color and Shape:SolidMolecular weight:461.52BNTX
CAS:<p>BNTX (7-Benzylidenenaltrexone) is a selective δ1-opioid receptor antagonist. It competitively counteracts the antisecretory effects of DPDPE, Deltorphin 2, and DAMGO. BNTX is applicable in research focused on antinociceptive effects.</p>Formula:C27H27NO4Color and Shape:SolidMolecular weight:429.508BMS-986118
CAS:<p>BMS-986118 is a GPR40 full agonist targeting type II diabetes, prompting insulin release without hypoglycemia risk.</p>Formula:C25H28ClF3N4O4Purity:98%Color and Shape:SolidMolecular weight:540.96(±)-J 113397
CAS:<p>(±)-J-113397 is a potent and selective non-peptidyl ORL1 receptor antagonist (K(i): cloned human ORL1=1.8 nM).</p>Formula:C24H37N3O2Color and Shape:SolidMolecular weight:399.57TD-0212
CAS:TD-0212: Oral dual antagonist for AT1 (pKi 8.9) & NEP inhibitor (pIC50 9.2).Formula:C28H34FN3O4SPurity:98%Color and Shape:SolidMolecular weight:527.65TD-0212 TFA
CAS:<p>TD-0212 TFA is an oral AT1 receptor antagonist & NEP inhibitor with pKi 8.9 & pIC50 9.2.</p>Formula:C30H35F4N3O6SPurity:98%Color and Shape:SolidMolecular weight:641.67GNTI dihydrochloride
CAS:<p>κ opioid receptor antagonist</p>Formula:C27H30ClN5O3Purity:98%Color and Shape:SolidMolecular weight:508.01J-113397
CAS:<p>J-113397 is a potent and selective NOP receptor antagonist (IC50 = 2.3 nM).</p>Formula:C24H37N3O2Purity:98%Color and Shape:SolidMolecular weight:399.57SC13
CAS:<p>SC13, a novel mitragynine analog, exhibits low-efficacy agonism at Mu opioid receptors and provides antinociception while minimizing adverse effects.</p>Formula:C26H30N2O5Color and Shape:SolidMolecular weight:450.53L 365209
CAS:<p>L 365209 is an oxytocin antagonist.</p>Formula:C40H50N8O6Purity:98%Color and Shape:SolidMolecular weight:738.88Mu opioid receptor antagonist 3
<p>Potent, selective MOR antagonist (compound 26); crosses blood-brain barrier. Ki: 0.24 nM, EC50: 0.54 nM; for studying OUD.</p>Formula:C25H28N2O4SColor and Shape:SolidMolecular weight:452.57AT1R antagonist 2
<p>AT1R antagonist 2 is a potent AT1R selective ligand with good AT1R affinity (Ki: 26 nM).</p>Formula:C29H37N5O4S2Color and Shape:SolidMolecular weight:583.77A4B17
<p>A4B17 is an inhibitor of androgen receptor N-terminal with potential for androgen-responsive prostate cancer treatment.</p>Formula:C14H7F4NSColor and Shape:SolidMolecular weight:297.27ER degrader 10
CAS:<p>ER degrader 10 (Compound 51) is an orally active estrogen receptor (ER) selective degrader and antagonist, with a DC50 of 0.43 nM and an IC50 of 0.56 nM. It inhibits the proliferation of ER-positive cells, with an IC50 ranging from 0 to 15 nM. ER degrader 10 exhibits weak inhibitory activity on the hERG channel, with an IC50 greater than 40 μM. It has blood-brain barrier permeability, with a brain/plasma ratio (Kp) of 3.05. In mouse models, ER degrader 10 demonstrates antitumor activity.</p>Formula:C28H29F2NO3SColor and Shape:SolidMolecular weight:497.597Allyphenyline oxalate
CAS:<p>The pKi values of Allyphenyline oxalate (compound 9) for the α2-adrenergic receptor subtypes α2A, α2B, and α2C are 7.24, 6.47, and 7.07, respectively.</p>Formula:C16H20N2O5Color and Shape:SolidMolecular weight:320.34BU09059
CAS:<p>BU09059 is a potent, selective, short-acting antagonist of the κ-opioid receptor (KOR).</p>Formula:C28H37N3O5Purity:98%Color and Shape:SolidMolecular weight:495.61Naldemedine tosylate
CAS:<p>Naldemedine (S-297995) tosylate, a PAMORA, targets μ-, δ-, κ-opioid receptors, aiding OIC research, may bind to SARS-CoV2's 3CL pro.</p>Formula:C39H42N4O9SColor and Shape:SolidMolecular weight:742.84LX1
CAS:<p>LX1, an anti-prostate cancer compound, specifically targets the androgen receptor (AR), AR variants, and the steroidogenic enzyme AKR1C3. It inhibits AKR1C3's enzymatic function, decreases the conversion of androstenedione to testosterone, and reduces the expression of both AR and AR-V7, subsequently downregulating their target genes. Additionally, LX1 is effective in overcoming tumor cell resistance to Enzalutamide, and when combined with Enzalutamide, it further suppresses tumor growth.</p>Formula:C22H15F6NO2Color and Shape:SolidMolecular weight:439.35Androgen receptor degrader-5
CAS:<p>Androgen receptor degrader-5 (compound 14k) demonstrates superior capabilities, specifically in androgen receptor degradation and antiproliferative activity, showcasing its promising properties.</p>Formula:C29H25F4N5O2Color and Shape:SolidMolecular weight:551.53FL442
CAS:<p>FL442 is an Androgen Receptor (AR) modulator. This compound exhibits potent inhibitory effects in AR-dependent prostate cancer cells, showing similar suppression efficiency to the traditional antiandrogen drugs Bicalutamide and Enzalutamide. It also maintains antiandrogen activity against the Enzalutamide-resistant AR mutant F876L. The pharmacokinetic properties of FL442 in mice reveal a longer half-life (8 hours), excellent targeting (prostate tissue), and metabolic stability. Additionally, it is effective at inhibiting LNCaP tumor growth at low plasma concentrations (30 ng/mL).</p>Formula:C15H13F3N2OColor and Shape:SolidMolecular weight:294.27LY2066948
CAS:<p>LY2066948 is a selective oral estrogen receptor modulator (SERM) with high affinity for estrogen receptors ERα and ERβ (Ki of 0.51 and 1.36 nM, respectively) and displays potent anti-estrogenic activity. It effectively blocks the increase in uterine weight induced by ethinylestradiol in immature rats. LY2066948 is utilized in the research of uterine fibroids and myomas.</p>Formula:C30H31NO5SColor and Shape:SolidMolecular weight:517.64(+)-JJ-74-138
CAS:<p>(+)-JJ-74-138 is a novel non-competitive androgen receptor (AR) antagonist capable of inhibiting enzalutamide-resistant castration-resistant prostate cancer (CRPC).</p>Formula:C22H22F8N2OSColor and Shape:SolidMolecular weight:514.48Androgen receptor ligand 1
CAS:<p>Androgen receptorligand 1 is a ligand for the androgen receptor (AR). It interacts with the CRBN E3 ligase via a linker to form an AR-PROTAC degrader. This compound is useful in prostate cancer research.</p>Formula:C19H16F4N2OColor and Shape:SolidMolecular weight:364.34OT-R agonist 1 TFA
CAS:<p>OT-R agonist 1 TFA (compound 5) is an oxytocin receptor (OT-R) agonist with an EC50 value of 0.39 nM. It exhibits V1A antagonist activity, with an EC50 value of 2432 nM, and can be utilized in studies related to central nervous system diseases.</p>Formula:C37H40F3N7O7SColor and Shape:SolidMolecular weight:783.82L162389
CAS:<p>L162389 is an angiotensin II receptor antagonist with a balanced affinity for AT1 and AT2 receptor and stimulates the conversion of phosphatidylinositol.</p>Formula:C31H38N4O4SPurity:99.11% - 99.57%Color and Shape:SolidMolecular weight:562.72Cort108297
CAS:<p>Cort108297: selective GR modulator/antagonist, high GR affinity (Ki: 0.45nM), no other steroid receptor affinity.</p>Formula:C26H25F4N3O3SPurity:98.36% - 99.94%Color and Shape:SolidMolecular weight:535.55GLPG0974
CAS:<p>GLPG0974 is an antagonist of FFA2/GPR43 with IC50 of 9 nM.</p>Formula:C25H25ClN2O4SPurity:99.8%Color and Shape:SolidMolecular weight:484.99ZD 7155 hydrochloride
CAS:<p>ZD 7155 hydrochloride is an angiotensin II receptor type 1 (AT1 receptor) antagonist.</p>Formula:C26H27ClN6OPurity:99.8%Color and Shape:SolidMolecular weight:474.98Nalmefene
CAS:<p>Nalmefene (ORF 11676) is a μ-opioid antagonist and partial κ agonist used in the study of opioid overdose and alcohol dependence.</p>Formula:C21H25NO3Purity:99.86%Color and Shape:SolidMolecular weight:339.43L-371,257
CAS:<p>L-371,257 is a competitive antagonist of oxytocin receptor with pA2 of 8.4 and Ki of 19 nM. L-371,257 shows a Ki of 3.7 nM for vasopressin receptor 1a.</p>Formula:C28H33N3O6Purity:99.79%Color and Shape:SolidMolecular weight:507.58(E/Z)-GSK5182
CAS:<p>GSK5182 is a racemic mix of (E/Z) isomers, a selective ERRγ inverse agonist (IC50: 79 nM), and induces ROS in liver cancer.</p>Formula:C27H31NO3Purity:97.58%Color and Shape:SolidMolecular weight:417.54LSZ-102
CAS:<p>LSZ-102 is an effective and selective degrader of estrogen receptor (IC50 = 0.2 nM) and can be used in studies about ERα positive breast cancer.</p>Formula:C25H17F3O4SPurity:98.56%Color and Shape:SolidMolecular weight:470.46ZK 216348
CAS:<p>ZK 216348 also binds to Progesterone and mineralocorticoid receptors (IC50s: 20.4 nM and 79.9 nM, respectively). ZK 216348 is a nonsteroidal selective glucocorticoid receptor agonist (IC50: 20.3 nM). ZK 216348 has an anti-inflammatory activity similar to</p>Formula:C24H23F3N2O5Purity:98%Color and Shape:SolidMolecular weight:476.45PSN632408
CAS:<p>PSN632408 is an optimized agonist of GPR119 receptors that display similar potency to OEA at both recombinant mouse and human GPR119 receptors (EC50: 5.6 and 7.9 uM, respectively).</p>Formula:C18H24N4O4Purity:98%Color and Shape:SolidMolecular weight:360.41Mapracorat
CAS:<p>Mapracorat (ZK-245186, BOL-303242X) is a selective glucocorticoid receptor agonist,anti-inflammatory agent for atopic dermatitis and allergic conjunctivitis.</p>Formula:C25H26F4N2O2Color and Shape:SolidMolecular weight:462.48(S)-Mapracorat
CAS:<p>(S)-Mapracorat is a selective and less active agonist of the glucocorticoid receptor.</p>Formula:C25H26F4N2O2Color and Shape:SolidMolecular weight:462.48ML314
CAS:<p>ML314 is a brain-permeable nonpeptide β-inhibin-biased neurotensin NTR1 receptor agonist (EC50: 1.9 μM), a biased neurotensin receptor ligand for methamphetamine abuse that inhibits NTR2 and GPR35.</p>Formula:C24H28N4O3Purity:99.52%Color and Shape:SolidMolecular weight:420.504Exemestane
CAS:<p>Exemestane (EXE) is an Aromatase Inhibitor. The mechanism of action of exemestane is as an Aromatase Inhibitor.</p>Formula:C20H24O2Purity:99.35% - 99.35%Color and Shape:White To Light Yellow Crystal PowderMolecular weight:296.4Budesonide
CAS:<p>Budesonide (Pulmicort), an anti-inflammatory corticosteroid, has shown the effective glucocorticoid activitie and few mineralocorticoid activities. According to reports, Budesonide has extensively inhibitory effects against multiple cells types and mediators referred to allergic and nonallergic-mediated inflammatory. What's more, the anti-inflammatory action of budesonide has been revealed to contribute to the effectiveness of asthma.</p>Formula:C25H34O6Purity:99.03% - 99.72%Color and Shape:Crystals SolidMolecular weight:430.53Ref: TM-T0094
Discontinued productRelacorilant
CAS:<p>Relacorilant is an oral glucocorticoid receptor antagonist with Ki of 7.2 nM, potential for treating Cushing's syndrome.</p>Formula:C27H22F4N6O3SPurity:98.53% - 99%Color and Shape:SolidMolecular weight:586.56Phosphoramidon Disodium
CAS:<p>Phosphoramidon Disodium (Phosphoramidon Disodium Salt) Salt is a metalloendopeptidase inhibitor, widely used as a biochemical tool.</p>Formula:C23H34N3Na2O10PPurity:98%Color and Shape:SolidMolecular weight:588.4821-Acetoxypregna-1,4,9(11),16-tetraene-3,20-dione
<p>21-Acetoxypregna-1,4,9(11),16-tetraene-3,20-dione is a valuable organic compound for life sciences research [Catalog No.: T67476, CAS No.: 37413-91-5].</p>Formula:C23H26O4Color and Shape:SolidMolecular weight:366.457AZD9496 maleate
CAS:<p>AZD9496 maleate is a highly potent and selective antagonist of the estrogen receptor alpha (ERα), exhibiting an IC50 value of 0.28 nM. This compound, AZD9496 maleate, is an orally bioavailable selective estrogen receptor degrader (SERD).</p>Formula:C29H29F3N2O6Color and Shape:SolidMolecular weight:558.554ERB-196
CAS:<p>Erb-196 is an estrogen receptor-receptor agonist with non-steroidal selectivity.</p>Formula:C17H10FNO2Purity:98%Color and Shape:SolidMolecular weight:279.27L-372662
CAS:<p>L-372662 is bioactive chemical.</p>Formula:C33H38N4O6Color and Shape:SolidMolecular weight:586.68PF-998425
CAS:<p>non-steroidal androgen receptor (AR) antagonist</p>Formula:C14H14F3NOPurity:98%Color and Shape:SolidMolecular weight:269.26GPR109 receptor agonist-2
CAS:<p>Compound 5, a selective GPR109a agonist, exhibits a pEC50 value of 5.53 [1].</p>Formula:C7H10N2O2Color and Shape:SolidMolecular weight:154.17Pamoic acid
CAS:<p>Pamoic acid is the orphan G protein-coupled receptor GPR35 agonist. Pamoic acid activates ERK and beta-arrestin2 and causes antinociceptive activity.</p>Formula:C23H16O6Purity:99.99%Color and Shape:Fine Yellow PowderMolecular weight:388.37Cebranopadol
CAS:<p>Cebranopadol (GRT6005) is an analgesic NOP and opioid receptor agonist with Kis of 0.9 nM, 0.7 nM, 2.6 nM, 18 nM for human NOP, μ-opioid (MOP), κ-opioid (KOP)</p>Formula:C24H27FN2OPurity:98.32% - 99.78%Color and Shape:SolidMolecular weight:378.48YK11
CAS:<p>YK11 is an androgen receptor partial agonist that activates androgen receptor transcriptional activity in HEK293 cells overexpressing androgen receptors when used at a concentration of 0.1 μM, with osteogenic activity.</p>Formula:C25H34O6Purity:98.91%Color and Shape:SoildMolecular weight:430.53SR17018
CAS:<p>SR17018 is an mu-opioid-receptor (MOR) agonist, binding with GTPγS, with an EC50 of 97 nM.</p>Formula:C19H18Cl3N3OPurity:99.89%Color and Shape:SolidMolecular weight:410.72Bromadoline maleate
CAS:<p>Bromadoline is an opioid analgesic selective for the μ-opioid receptor.</p>Formula:C19H25BrN2O5Purity:98%Color and Shape:SolidMolecular weight:441.322Ceronapril
CAS:<p>Ceronapril (SQ 29852) is an orally active and potent angiotensin-converting enzyme (ACE) inhibitor (IC50 : 36 nM) for the study of dementia and hypertension.</p>Formula:C21H33N2O6PPurity:97.94%Color and Shape:SolidMolecular weight:440.47Ref: TM-T25226
Discontinued productSR14150
CAS:<p>SR14150 is a partial agonist of high-affinity NOP receptor.</p>Formula:C21H30N2OPurity:98%Color and Shape:SolidMolecular weight:326.48MOR agonist-1
CAS:<p>MOR Agonist-1 is a μ-opioid receptor (MOR) agonist noted for its potent analgesic properties and is utilized in research concerning pain and associated</p>Formula:C22H26ClFN2O2Purity:98%Color and Shape:SolidMolecular weight:404.91Estrogen receptor modulator 8
CAS:<p>Estrogen Receptor Modulator 8 (compound 4) is an orally active inhibitor targeting Estrogen Receptor/ERR α with potent efficacy (IC50 = 0.437 nM in MCF-7 cells</p>Formula:C25H24F4N2O2Purity:98%Color and Shape:SolidMolecular weight:460.46ALS-I-41
CAS:<p>ALS-I-41 is a novel, potent and selective antagonist of oxytocin receptor.</p>Formula:C30H38FN3O6SPurity:98%Color and Shape:SolidMolecular weight:587.7
